Latest filing published 05 May 2020 for Gilead Sciences, INC., €43k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Francis Cogan: trading record in brief
John Francis Cogan is a declared insider at 2 companies; the most frequent names are Gilead Sciences, Inc. and Monaco Coach Corp /DE/. In total, 127 filings cover trades dated from 3 April 2006 to 4 May 2020.
On the open market, the record shows 8 purchases worth €38k and 59 sales worth €30.5M. The net balance comes to €30.4M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 59 option exercises. So far in 2020, the count stands at no purchases and 9 sales.
In size, the median ticket on the buying side is €4,695.
On 5 May 2020 came the latest disclosure, an option exercise for €43k in Gilead Sciences, Inc. The last purchase on record was published on 2 January 2008, which is 6,885 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Francis Cogan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,416 shares@ US$19.632.3% of flowCommon StockSEC:0001127602-20-015427:0
- 2,416 shares@ US$81.759.4% of flowCommon StockSEC:0001127602-20-015427:1
- 2,413 shares@ US$19.632.3% of flowCommon StockSEC:0001127602-20-014714:0
- 2,413 shares@ US$79.909.3% of flowCommon StockSEC:0001127602-20-014714:1
- 2,413 shares@ US$19.632.3% of flowCommon StockSEC:0001127602-20-014247:0
- 2,413 shares@ US$83.009.6% of flowCommon StockSEC:0001127602-20-014247:1
- 2,413 shares@ US$19.632.3% of flowCommon StockSEC:0001127602-20-013679:0
- 2,413 shares@ US$75.908.7% of flowCommon StockSEC:0001127602-20-013679:1
- 2,413 shares@ US$19.632.3% of flowCommon StockSEC:0001127602-20-013405:0
- 2,413 shares@ US$79.529.2% of flowCommon StockSEC:0001127602-20-013405:1
- 2,413 shares@ US$19.632.2% of flowCommon StockSEC:0001127602-20-012212:0
- 2,413 shares@ US$75.358.6% of flowCommon StockSEC:0001127602-20-012212:1
- 2,413 shares@ US$19.632.3% of flowCommon StockSEC:0001127602-20-011900:0
- 2,413 shares@ US$75.278.8% of flowCommon StockSEC:0001127602-20-011900:1
- 2,413 shares@ US$19.632.2% of flowCommon StockSEC:0001127602-20-011172:0
- 2,413 shares@ US$67.267.6% of flowCommon StockSEC:0001127602-20-011172:1
- 2,413 shares@ US$19.632.2% of flowCommon StockSEC:0001127602-20-010172:0
- 2,413 shares@ US$77.978.6% of flowCommon StockSEC:0001127602-20-010172:1
- 2,868 shares@ US$22.020.9% of flowCommon StockSEC:0001127602-19-017097:0
- 2,868 shares@ US$64.892.7% of flowCommon StockSEC:0001127602-19-017097:1
- 2,700 shares@ US$22.020.9% of flowCommon StockSEC:0001127602-19-016245:0
- 2,700 shares@ US$62.612.4% of flowCommon StockSEC:0001127602-19-016245:1
- 2,700 shares@ US$22.020.8% of flowCommon StockSEC:0001127602-19-015848:0
- 2,600 shares@ US$64.212.4% of flowCommon StockSEC:0001127602-19-015848:1
- 100 shares@ US$64.660.1% of flowCommon StockSEC:0001127602-19-015848:2
25 of 118 declarations